The US Supreme Court has temporarily halted the process of mail delivery for the first time, following a decision by the 5th U.S. Circuit Court of Appeals to re-impose an older federal rule requiring an in-person clinician to receive mifepristone. This decision was made in response to a challenge by the Republican-led state of Louisiana. The Supreme Court's decision gives the justices more time to review emergency requests by two manufacturers of mefepriston to ensure the drug can be provided via telehealth and the mail while the legal challenge plays out in lower courts. The case puts the contentious issue of abortion back in front of the justices, as they face another attempt by abortion opponents to reduce access to the drug.